ASSESSMENT, INTERVENTION AND MEASUREMENT (AIM) The Assessment, Intervention and Measurement (AIM) facility is the only shared resource at MD Anderson that provides expertise in the science of collecting and managing patient-reported outcome data, assessing energy balance, and developing and implementing technology applications for behavioral assessment and intervention.
AIM i s a merger of the former CCSG core, Patient-Reported Outcomes, Survey and Population Research (PROSPR), and the CCSG Developing core, e-Health Technology (EHT). Consolidation of these two resources provided a more cost-efficient and integrated population research core facility.
AIM i s led by Dr. Susan Peterson (director), a professor in the Department of Behavioral Science, and Dr. Karen Basen-Engquist (co-director), a professor in the Department of Behavioral Science and the director of the Center for Energy Balance Research in Cancer Prevention and Survivorship. In the past 6 years, services have been provided to 105 center members in all 16 CCSG programs. Utilization of services provided by the AIM facility has increased 60% since grant Yr37 with 20% of the increase from the former PROSPR facility. Usage has diversified over the past 6 years with an increased number of users from clinical and translational CCSG programs. Peer review-funded usage accounted for 96% of AIM's total usage in Yr42; non-peer review funding accounted for 4% of its usage. In the past year, services have been provided to 36 center members in 12 of 16 CCSG programs with a similar fraction of peer- reviewed usage over the 6-year period. Population science programs accounted for 39% of AIM's usage, and clinical-translational CCSG programs' combined usage accounted for 50% of AIM's total usage. Current CCSG support accounts for 24% ($236,054) of the operating budget, chargebacks account for 45% ($441,576), and institutional support accounts for 31% ($306,914). In Yr44, AIM is requesting $278,346 (32%) in CCSG funding.
AIM has provided support for 75 publications since the previous grant period; 14 (19%) were in journals with IF >5.
The Specific Aims are:
Aim 1. To provide expertise in the science of collecting and managing patient- reported outcome data, including that collected with surveys, web applications, and mobile applications.
Aim 2. To provide expertise in energy balance research, including the assessment of diet, physical activity, and physical functioning, and in the delivery of physical activity interventions.
Aim 3. To provide expertise in the development and implementation of mobile, web, and sensor applications for behavioral assessment and intervention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-43
Application #
9794664
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Sankhala, Kamalesh; Takimoto, Chris H; Mita, Alain C et al. (2018) Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules. Invest New Drugs :
Shen, Weining; Ning, Jing; Yuan, Ying et al. (2018) Model-free scoring system for risk prediction with application to hepatocellular carcinoma study. Biometrics 74:239-248
Wu, Shaofang; Wang, Shuzhen; Gao, Feng et al. (2018) Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma. Neuro Oncol 20:78-91
Romano, Gabriele; Chen, Pei-Ling; Song, Ping et al. (2018) A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling. Cancer Discov 8:556-567
Dray, Beth K; Raveendran, Muthuswamy; Harris, R Alan et al. (2018) Mismatch repair gene mutations lead to lynch syndrome colorectal cancer in rhesus macaques. Genes Cancer 9:142-152
Keene, Kimberly S; King, Tari; Hwang, E Shelley et al. (2018) Molecular determinants of post-mastectomy breast cancer recurrence. NPJ Breast Cancer 4:34
Zhang, Miao; Adeniran, Adebowale J; Vikram, Raghunandan et al. (2018) Carcinoma of the urethra. Hum Pathol 72:35-44
Ciurea, Stefan O; Bittencourt, Maria Cecilia Borges; Milton, DenĂ¡i R et al. (2018) Is a matched unrelated donor search needed for all allogeneic transplant candidates? Blood Adv 2:2254-2261
Chiu, Hua-Sheng; Somvanshi, Sonal; Patel, Ektaben et al. (2018) Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context. Cell Rep 23:297-312.e12
Zhang, Yu; Zoltan, Michelle; Riquelme, Erick et al. (2018) Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Gastroenterology 155:210-223.e3

Showing the most recent 10 out of 12418 publications